ORION CORPORATION INTERIM REPORT 1-9/2021 20 OCTOBER 2021 at 12:00 noon EEST Orion Group Interim Report 1-9/2021 This is a summary of Orion's Interim Report 1-9/2021. The
Orion Oyj: 90,889 Orion Corporation A shares converted into B shares finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ORION CORPORATION INVESTOR NEWS 26 MAY 2021 at 10.15 EEST Orion's Virtual Capital Markets Day today at 13.00 EEST - presentation material now available Orion will arrange
Orion Oyj: Invitation to Orion s Virtual Capital Markets Day on 26 May 2021
Invitation to on 26 May 2021
Orion will arrange a virtual Capital Markets Day 2021 for investors, analysts and media on 26 May 2021 at 13:00-16:00 EEST. At the event, Orion s management will provide an update on the company s strategy and targets, business and research & development projects. The presentations are divided into two main themes which are Creating growth towards 2025 target and beyond and Creating long-term value .
Speakers and programme
Timo Lappalainen, President & CEO
Satu Ahomäki, SVP, Proprietary Products and Commercial Operations
Niclas Lindstedt, VP, Animal Health
Virve Laitinen, SVP, Specialty Products
Jari Karlson, CFO
Strong first quarter as exceptional circumstances continue
“In the early part of 2021, the exceptional circumstances brought on by the COVID-19 pandemic are still prevailing. For Orion, this means continuing to focus on looking after the health and safety of our employees and ensuring production continuity, product availability and patient safety in ongoing clinical trials.
In January–March 2021, Orion s net sales were EUR 269 (280) million and operating profit EUR 75 (84) million. As anticipated, they fell below the robust comparative period when the peak in demand for pharmaceuticals caused by the COVID-19 pandemic gave a boost to sales and profits. The Specialty Products unit had a good quarter even though due to the coronavirus pandemic and related restrictions implemented in various countries, the prevalence of seasonal illnesses such as the common flu has been lower than normal, and there has been a decline in non-critical procedures and medical appointments. The pandemi